Alexandria P. Cogdill
Daiichi Sankyo (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Gut microbiota and health
Most-Cited Works
- → Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients(2017)4,526 cited
- → B cells and tertiary lymphoid structures promote immunotherapy response(2020)2,551 cited
- → The human tumor microbiome is composed of tumor type–specific intracellular bacteria(2020)2,260 cited
- → COT drives resistance to RAF inhibition through MAP kinase pathway reactivation(2010)1,444 cited
- → Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen(2009)1,391 cited
- → Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade(2017)1,238 cited
- → EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib(2012)1,018 cited
- → BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma(2013)936 cited
- → Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells(2018)838 cited
- → Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response(2021)834 cited